Target : Phase I, monocenter cross-over trial, evaluating the anti-platelet effect of IV administred clopidogrel (MDCO-157) versus orally administered clopidogrel.

Trial date : 2012

Number of patients : 33

Source of funding : Private (The Medicines Company)

Centers participating : Monocentric (Pitié-Salpêtrière)

N°NCT : NCT01860105

STATUS

Publication in Am J Cardiovasc Drugs – fev 2016